ALAmax CR™, a potent oxidative stress antagonist, is a proprietary, orally active, controlled-release formulation of racemic a-lipoic acid (containing both R and S enantiomers) that has a pharmacokinetic advantage over other alpha lipoic acid formulas. Other brands are cleared from the plasma within two-three hours; whereas, ALAmax CR™ remains in the plasma for four to six hours.
U.S. Patents: 6,191,162(B1); 6,197,340(B1); 6,572,888(B2); 7,118,762(B2).
Updating...
